메뉴 건너뛰기




Volumn 21, Issue , 2014, Pages 18-25

Optimising exercise training in prevention and treatment of diastolic heart failure (OptimEx-CLIN): Rationale and design of a prospective, randomised, controlled trial

Author keywords

diastolic heart failure; exercise capacity; exercise training; Heart failure; heart failure with preserved ejection fraction; interval training; telemonitoring; training intensity

Indexed keywords

ACTIMETRY; CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEVICES; ELECTROCARDIOGRAPHY; EUROPE; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE, DIASTOLIC; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; HUMAN; KINESIOTHERAPY; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PREDICTIVE VALUE; PREVENTIVE HEALTH SERVICE; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIGNAL PROCESSING; TELEMEDICINE; TELEMETRY; TIME; TRANSDUCER; TREATMENT OUTCOME;

EID: 84927777037     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314552764     Document Type: Article
Times cited : (58)

References (19)
  • 1
    • 77953593318 scopus 로고    scopus 로고
    • HFSA 2010 comprehensive heart failure practice guideline
    • Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010; 16: e1–e194.
    • (2010) J Card Fail , vol.16 , pp. e1-e194
    • Lindenfeld, J.1    Albert, N.M.2    Boehmer, J.P.3
  • 2
    • 33746088001 scopus 로고    scopus 로고
    • Trends in prevalence and outcome of heart failure with preserved ejection fraction
    • Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251–259.
    • (2006) N Engl J Med , vol.355 , pp. 251-259
    • Owan, T.E.1    Hodge, D.O.2    Herges, R.M.3
  • 3
    • 70349231338 scopus 로고    scopus 로고
    • Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy
    • Stolen TO, Hoydal MA, Kemi OJ, et al. Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res 2009; 105: 527–536.
    • (2009) Circ Res , vol.105 , pp. 527-536
    • Stolen, T.O.1    Hoydal, M.A.2    Kemi, O.J.3
  • 4
    • 84870556584 scopus 로고    scopus 로고
    • What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?
    • Campbell RT, Jhund PS, Castagno D, et al. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol 2012; 60: 2349–2356.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 2349-2356
    • Campbell, R.T.1    Jhund, P.S.2    Castagno, D.3
  • 5
    • 33748988737 scopus 로고    scopus 로고
    • The perindopril in elderly people with chronic heart failure (PEP-CHF) study
    • Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338–2345.
    • (2006) Eur Heart J , vol.27 , pp. 2338-2345
    • Cleland, J.G.1    Tendera, M.2    Adamus, J.3
  • 6
    • 84867745957 scopus 로고    scopus 로고
    • The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial
    • Solomon SD, Zile M, Pieske B, et al. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial. Lancet 2012; 380: 1387–1395.
    • (2012) Lancet , vol.380 , pp. 1387-1395
    • Solomon, S.D.1    Zile, M.2    Pieske, B.3
  • 7
    • 0041408234 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
    • Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777–781.
    • (2003) Lancet , vol.362 , pp. 777-781
    • Yusuf, S.1    Pfeffer, M.A.2    Swedberg, K.3
  • 8
    • 77950223587 scopus 로고    scopus 로고
    • Mode of death in patients with heart failure and a preserved ejection fraction: Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial
    • Zile MR, Gaasch WH, Anand IS, et al. Mode of death in patients with heart failure and a preserved ejection fraction: Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 2010; 121: 1393–1405.
    • (2010) Circulation , vol.121 , pp. 1393-1405
    • Zile, M.R.1    Gaasch, W.H.2    Anand, I.S.3
  • 9
    • 84874367056 scopus 로고    scopus 로고
    • Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The Aldo-DHF randomized controlled trial
    • Edelmann F, Wachter R, Schmidt AG, et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The Aldo-DHF randomized controlled trial. JAMA 2013; 309: 781–791.
    • (2013) JAMA , vol.309 , pp. 781-791
    • Edelmann, F.1    Wachter, R.2    Schmidt, A.G.3
  • 10
    • 84898713808 scopus 로고    scopus 로고
    • Spironolactone for heart failure with preserved ejection fraction
    • Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014; 370: 1383–1392.
    • (2014) N Engl J Med , vol.370 , pp. 1383-1392
    • Pitt, B.1    Pfeffer, M.A.2    Assmann, S.F.3
  • 11
    • 84868203473 scopus 로고    scopus 로고
    • EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations
    • Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012; 126: 2261–2274.
    • (2012) Circulation , vol.126 , pp. 2261-2274
    • Guazzi, M.1    Adams, V.2    Conraads, V.3
  • 12
    • 80054768603 scopus 로고    scopus 로고
    • Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study
    • Edelmann F, Gelbrich G, Dungen HD, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 2011; 58: 1780–1791.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 1780-1791
    • Edelmann, F.1    Gelbrich, G.2    Dungen, H.D.3
  • 13
    • 34548525319 scopus 로고    scopus 로고
    • How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
    • Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539–2550.
    • (2007) Eur Heart J , vol.28 , pp. 2539-2550
    • Paulus, W.J.1    Tschope, C.2    Sanderson, J.E.3
  • 14
    • 84903170344 scopus 로고    scopus 로고
    • 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: B2960–B2984.
    • (2014) J Am Coll Cardiol , vol.63 , pp. B2960-B2984
    • Eckel, R.H.1    Jakicic, J.M.2    Ard, J.D.3
  • 15
    • 84882870551 scopus 로고    scopus 로고
    • Exercise standards for testing and training: A scientific statement from the American Heart Association
    • Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 2013; 128: 873–934.
    • (2013) Circulation , vol.128 , pp. 873-934
    • Fletcher, G.F.1    Ades, P.A.2    Kligfield, P.3
  • 17
    • 80051994560 scopus 로고    scopus 로고
    • Telemedicine and remote management of patients with heart failure
    • Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 2011; 378: 731–739.
    • (2011) Lancet , vol.378 , pp. 731-739
    • Anker, S.D.1    Koehler, F.2    Abraham, W.T.3
  • 18
    • 77955173009 scopus 로고    scopus 로고
    • Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association
    • Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association. Circulation 2010; 122: 406–441.
    • (2010) Circulation , vol.122 , pp. 406-441
    • Artinian, N.T.1    Fletcher, G.F.2    Mozaffarian, D.3
  • 19
    • 64249125022 scopus 로고    scopus 로고
    • Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
    • O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301: 1439–1450.
    • (2009) JAMA , vol.301 , pp. 1439-1450
    • O'Connor, C.M.1    Whellan, D.J.2    Lee, K.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.